​
​

Finch Therapeutics Group Ownership | Who Owns Finch Therapeutics Group?

OverviewForecastRevenueFinancialsChart

Finch Therapeutics Group Ownership Summary

Finch Therapeutics Group is owned by 1.32% institutional investors, 53.46% insiders, and 45.22% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.01% of its assets in Finch Therapeutics Group shares.

FNCH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFinch Therapeutics Group1.32%53.46%45.22%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-90.00%21,206-83.58%12.04%--100.00%--100.00%
Mar 31, 202410-33.33%129,112-38.27%84.73%4-20.00%2-
Dec 31, 202315-6.25%209,157-14.15%135.66%566.67%--100.00%
Sep 30, 2023166.67%243,617-1.30%156.42%3200.00%4-71.43%
Jun 30, 20231-96.77%55,445-99.42%-26.31%--100.00%1-88.89%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr16.23K1.01%-
Vanguard Total Stock Mkt Idx Inv9.71K0.60%-10.31K
Greenwich Ivy Long-Short Instl7.50K0.47%-
Fidelity Extended Market Index3.71K0.23%-
Fidelity Total Market Index1.61K0.10%-
Fidelity Nasdaq Composite Index849.000.05%-
Northern Trust Extended Eq Market Idx571.000.04%-
NT Ext Equity Mkt Idx Fd - L571.000.04%-
Spartan Total Market Index Pool E484.000.03%-
NT Ext Equity Mkt Idx Fd - NL240.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 28, 2024SMISEK JEFFERY A-Sell$17.07K
Mar 28, 2024SMISEK JEFFERY A-Sell$4.18K
Nov 22, 2023SMISEK JEFFERY A-Sell$5.35K
Jun 09, 2023Graf Susan E-Buy$1.35K
Feb 21, 2023Blaustein Marc Chief Operating OfficerSell$1.76K

Insider Transactions Trends

DateBuySell
2024 Q1-2
2023 Q4-1
2023 Q21-
2023 Q1-1
2022 Q4-2

FNCH Ownership FAQ

Who Owns Finch Therapeutics Group?

Finch Therapeutics Group shareholders are primarily institutional investors at 1.32%, followed by 53.46% insiders and 45.22% retail investors. The average institutional ownership in Finch Therapeutics Group's industry, Biotech Stocks , is 44.70%, which Finch Therapeutics Group falls below.

Does Blackrock own Finch Therapeutics Group?

BlackRock is not among the top 10 institutional shareholders of Finch Therapeutics Group.

Who is the top mutual fund holder of Finch Therapeutics Group shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Finch Therapeutics Group shares, with 1.01% of its total shares outstanding invested in 16.23K Finch Therapeutics Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools